BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19845741)

  • 1. Significance of quantitative measurement of heparin-induced platelet antibodies.
    Javela K; Kekomäki R; Koskinen S
    Eur J Haematol; 2010 Feb; 84(2):169-74. PubMed ID: 19845741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies.
    Morel-Kopp MC; Aboud M; Tan CW; Kulathilake C; Ward C
    Thromb Res; 2010 May; 125(5):e234-9. PubMed ID: 20053425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
    Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
    Chilver-Stainer L; Lämmle B; Alberio L
    Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
    Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
    Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
    Nowak G
    Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke.
    Kawano H; Toyoda K; Miyata S; Yamamoto H; Okamoto A; Kakutani I; Walenga JM; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2008; 26(6):641-9. PubMed ID: 18984950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
    Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
    Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
    Fretschner R; Dietrich K; Unertl K; Greinacher A
    Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
    Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
    Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
    Chong BH; Eisbacher M
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory testing for VITT antibodies.
    Warkentin TE; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune heparin-induced thrombocytopenia.
    Greinacher A; Selleng K; Warkentin TE
    J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.